Steady-State Kinetics of the Quinolone Derivatives Ofloxacin, Enoxacin, Ciprofloxacin and Pefloxacin during Maintenance Treatment with Theophylline
- 1 January 1987
- journal article
- research article
- Published by Springer Nature in Drugs
- Vol. 34 (Supplement) , 159-169
- https://doi.org/10.2165/00003495-198700341-00034
Abstract
Some of the new quinolone derivatives may be of value in the treatment of respiratory tract infections. It has been demonstrated that enoxacin, pefloxacin and ciprofloxacin, but not ofloxacin, decreased the metabolic clearance of the bronchodilator theophylline. This resulted in elevated plasma theophylline concentrations and, in some of the patients, theophylline toxicity. When the pharmacokinetic parameters of enoxacin, pefloxacin, ciprofloxacin and ofloxacin obtained in the present study were compared with those obtained from other studies in healthy volunteers not given concomitant theophylline, there was no evidence of theophylline influencing the clearance of the investigated quinolones.Keywords
This publication has 22 references indexed in Scilit:
- Enoxacin in lower respiratory tract infectionsJournal of Antimicrobial Chemotherapy, 1986
- Pharmacokinetics of ciprofloxacin in healthy volunteers after oral and intravenous administrationEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Pharmacokinetics of intravenously administered ciprofloxacin in intensive care patients with acute renal failureInternational Journal of Clinical Pharmacy, 1986
- Fluorinated quinolonesInternational Journal of Clinical Pharmacy, 1986
- Pharmacokinetics: metabolism and renal excretion of quinolones in manInternational Journal of Clinical Pharmacy, 1986
- Pharmacokinetics of pefloxacin in renal insufficiencyEuropean Journal of Clinical Pharmacology, 1985
- Dose-Dependent Pharmacokinetic Study of Pefloxacin, a New Antibacterial Agent, in HumansJournal of Pharmaceutical Sciences, 1984
- Comparative in vitro activity of five quinoline derivatives and five other antimicrobial agents used in oral therapyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Absorption, distribution, metabolic fate, and elimination of pefloxacin mesylate in mice, rats, dogs, monkeys, and humansAntimicrobial Agents and Chemotherapy, 1984
- Pharmacology of Cinoxacin in HumansAntimicrobial Agents and Chemotherapy, 1979